Amgen Ventures is the venture capital arm of Amgen Inc., focusing on investments in emerging biotechnology companies that align with Amgen's strategic interests in innovative therapeutics and technologies. The fund targets areas such as oncology, hematology, and chronic inflammatory diseases, leveraging Amgen's expertise to support portfolio companies in advancing healthcare solutions.
Recent Transactions involving Amgen Ventures
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama |
Saama Technologies |
Pfizer VenturesAmgen VenturesNorthpond VenturesPopulation Health PartnersThe Carlyle GroupMcKesson VenturesMerck Global Health Innovation FundIntermountain Ventures |
Life Sciences Technology | |
|
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →